HZHongrui Zhu

Hongrui Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hongrui Zhu has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Sheng Wang

    Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China

    14 shared publications
  • Mengmeng Yang

    Department of Pain and Anesthesiology, The First Affiliated Hospital of USTC, State Key Laboratory of Immune Responses and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    9 shared publications
  • Li Peng

    Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 16 Lujiang Road, Hefei City, 230001, Anhui, People's Republic of China

    6 shared publications
  • Shuaijie Sun

    Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 16 Lujiang Road, Hefei City, 230001, Anhui, People's Republic of China

    6 shared publications
  • Chunliu Li

    Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China

    5 shared publications
  • Jun Li

    Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 16 Lujiang Road, Hefei City, 230001, Anhui, People's Republic of China

    5 shared publications

Latest Publications

  • Open Access

    Metabolic licensing of quiescent glioblastoma activation and immune evasion via astrocyte-mitochondria shuttle

    by Hongrui Zhu, Li Wang, Qi Wu, Yanwei Yu, Mengmeng Yang, Youqiong Ye, Wenchao Zhou, Jiabei Wang, Xuedan Sun, Sheng Wang, et al.

    Reactivating quiescent tumor cells at the invasive margin are either eliminated by immune surveillance or expand through immune escape. The mechanisms underpinning phenotypic plasticity driving expansion leading to therapeutic resistance, dissemination, and recurrence remain elusive. Here we establish a metabolic licensing paradigm wherein reactive astrocytes awaken dormant glioblastoma cells and simultaneously confer immune evasion through intercellular mitochondrial transfer. Astrocyte-derived mitochondria, enriched with the one carbon metabolism enzyme SHMT2, deliver functional metabolic units that reprogram recipient glioma cells. This shuttled cargo fuels S adenosylmethionine production, driving m⁶A RNA methylation and release of paused RNA polymerase II over a specific set of genes. Ribosome biogenesis and focal adhesion pathways are selectively upregulated consequently, which enables rapid proliferation and immune resistance of tumour cells. Genetic ablation of astrocytic Shmt2 or pharmacological blockade of mitochondrial transfer suppresses quiescent cell reactivation and delays tumor progression. Our findings thus establish the astrocyte-mitochondria shuttle as a core vulnerability in glioblastomas, linking metabolic crosstalk to epitranscriptomic control of reactivation and immune escape.

  • Open Access

    Identification of Risk Factors and Development of a Prediction Model for Recovery Room Delirium Following Transurethral Resection of the Prostate

    by Zhen Jiang, Hongrui Zhu, Ting Wang, Kai Zhao, Chuanyao Li, Chen Gao, Ling Zhou, Keqiang He

    Purpose: To identify independent risk factors for recovery room delirium (RRD) in patients undergoing transurethral resection of the prostate (TURP) and to develop a predictive model for early identification of high-risk patients. Patients and Methods: We retrospectively reviewed 1166 adult patients who underwent TURP under general anesthesia between January 2020 and December 2024. RRD was assessed using the 3-minute Diagnostic Interview for CAM-defined Delirium (3D-CAM). Patients were randomly assigned to the training set (n = 816) and the validation set (n = 350). Independent risk factors were identified by multivariate logistic regression, and a nomogram was constructed. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA). Results: The incidence of RRD was 19.5% in the training set and 20% in the validation set. Multivariable logistic regression identified older age, higher ASA physical status classification, preoperative hypoalbuminemia, intraoperative hypothermia, and intraoperative hypotension as independent predictors associated with an increased risk of RRD. Based on these predictors, a nomogram was established. The model demonstrated good discrimination, with an AUC of 0.841 (95% CI, 0.806– 0.876) in the training cohort and 0.858 (95% CI, 0.810– 0.906) in the validation cohort. Calibration analysis showed good agreement between the predicted and observed probabilities, and decision curve analysis demonstrated favorable clinical utility across a wide range of threshold probabilities. Conclusion: The RRD prediction model incorporating age, ASA classification, preoperative hypoalbuminemia, intraoperative hypothermia, and hypotension demonstrated promising discriminatory ability and calibration in this single-center cohort. However, prospective external validation is required before widespread clinical implementation.

  • Open Access

    Sevoflurane ameliorates cerebral ischemia–reperfusion injury by modulating mitochondrial dynamics and attenuating apoptosis via Shh-YAP1 signaling pathway

    by Li Peng, Mengmeng Yang, Jiayuan Liu, Tianyue Yin, Jun Li, Shuaijie Sun, Hongrui Zhu, Sheng Wang

    Ischemia-reperfusion injury (IRI) is a critical issue in the prevention and treatment of ischemic stroke. Inhalational anesthetics have been proven to have neuroprotective effects and sevoflurane is currently the most commonly used inhaled anesthetic in the clinic. However, the effects and underlying mechanism of sevoflurane on cerebral IRI have not been fully elucidated. In this study, oxygen-glucose deprivation model was established in primary mouse cortical neurons and HT22 cells, while the middle cerebral artery occlusion model was established in mice. Using laser speckle imaging, TTC staining, HE staining, Nissl staining, flow cytometry, calcium imaging and neurologic deficit scoring, we found that sevoflurane post-conditioning (SPC) significantly increased cerebral blood flow, reduced the infarct volume, alleviated neuronal pathological damage, promoted the survival of cortical neurons, reduced cell apoptosis, enhanced calcium responses and decreased the neurologic deficit scores after IRI. The results of RNA sequencing, Western blot, co-immunoprecipitation, TUNEL staining, immunofluorescence, transmission electron microscopy imaging, MPTP measurement, MMP detection, and ATP production measurement showed that the sonic hedgehog (Shh) signaling pathway crosstalk with Hippo-YAP signaling pathway, and the Shh-YAP1 pathway regulated mitochondrial dynamics and mitochondrial ultrastructure and function. In addition, SPC affected the phosphorylation and SUMOylation of dynamin-related protein 1 (Drp1), and there was an interaction between the phosphorylation and SUMOylation of Drp1. In conclusion, this study revealed that SPC might affect the phosphorylation and SUMOylation of Drp1 through the Shh-YAP1 signaling pathway, regulating mitochondrial dynamics, reducing cell apoptosis and ameliorating IRI. These findings offer new insights into the therapeutic strategies for ischemic stroke.


  • Open Access

    Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism

    by Rui Sun, Xu Wang, Zaibao Wang, Chunliu Li, Qing Shao, Xiangru Liu, Hongrui Zhu, Sheng Wang, Keqiang He

    Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment, posing significant challenges to affected individuals, their families, and healthcare systems globally. With projections indicating that the prevalence of AD could escalate to 152 million cases by 2050, there is an urgent need to elucidate the underlying mechanisms driving this condition. Additionally, developing effective diagnostic tools to aid in its early detection and management is crucial. Methods: In this study, we utilized a combination of Mendelian randomization and advanced machine learning techniques to analyze transcriptomic data from five distinct cohorts of Alzheimer's Disease (AD) patients. After addressing batch effects, we identified differentially expressed genes (DEGs) between the AD and control groups. Mendelian randomization analysis was conducted to assess the causal relationships between DEGs and AD risk. A Venn diagram was subsequently used to identify genes associated with cholesterol metabolism from the screened gene set. The shared DEGs were subjected to functional enrichment analyses. Furthermore, immune analysis was quantified using Gene Set Enrichment Analysis (GSEA). A diagnostic model for AD was developed by evaluating 113 combinations of 12 machine learning algorithms with 10‐fold cross‐validation on the training datasets, followed by external validation on test datasets. Finally, immunofluorescence staining was performed on mouse brain slices to verify the expression level of KLHL21. Results: Our analyses identified a substantial number of differentially expressed genes (DEGs) demonstrating significant differences between Alzheimer's disease (AD) patients and control groups. Among these, we identified 29 genes associated with AD, with 21 of them linked to cholesterol metabolism, highlighting its pivotal role in the disease's pathogenesis. From this set, we developed a robust 8‐gene diagnostic signature (comprising CHSY1, FIBP, DHCR24, HVCN1, KIFAP3, KLHL21, LETMD1, and SLC25A29), which outperformed existing AD diagnostic models in both training and testing cohorts. Additionally, complementary animal experiments were conducted to validate the biological relevance of these genes, further elucidating their roles in AD pathology. Conclusions: Our research identified critical genes and proposed novel pathways for early diagnosis and potential therapeutic interventions, paving the way for enhanced clinical applications in Alzheimer's disease management.


  • Open Access

    Astrocytic glycogen aggregates induce ATAD3A oligomerization mediated mitochondrial fragmentation and impede stroke recovery

    by Hongrui Zhu, Mengmeng Yang, Zhong Li, Chunliu Li, Shuaijie Sun, Xiangru Liu, Li Wang, Jiaming Zhang, Qing Shao, Keqiang He, et al.

    Ischemic stroke induces pathological glycogen deposition in astrocytes, but its role in post-injury neural dysfunction remains undefined. We reveal that glycogen-laden astrocytes in the ischemic penumbra undergo ATAD3A-dependent mitochondrial fragmentation via a stress granule-mediated mechanism, exacerbating neuronal injury and hindering functional recovery. Mechanistic studies demonstrate that glycogen aggregates sequester cytoplasmic HDAC3, enabling its translocation to mitochondria. There, HDAC3 deacetylates outer mitochondrial membrane protein ATAD3A, promoting oligomerization-driven mitochondrial fission. Astrocyte-specific ATAD3A ablation prevents stroke-induced synaptic disorganization, neural circuit disruption, and cognitive deficits. Therapeutically, pharmacologic or genetic exhaustion of astrocytic glycogen and HDAC3 inhibition reverse glycogen accumulation, rescue mitochondrial architecture/function, and restore synaptic plasticity and circuit reorganization, thereby acting synergistically to enhance post-stroke recovery. Our work identifies glycogen stress granules as pathogenic signaling hubs linking astrocytic metabolic stress to mitochondrial failure through compartmentalized HDAC3-ATAD3A crosstalk, and proposes a dual-target paradigm addressing both substrate overload and protein acetylation dynamics for stroke neurorestoration.

  • Open Access

    Compromised hepatic bilirubin clearance drives depressive symptoms via regulating microglial engulfment of dendritic spines

    by Shuaijie Sun, Mengyu Li, Jun Ma, Keqiang He, Li Wang, Chunliu Li, Xiangru Liu, Shiyuan Zhang, Tianyue Yin, Mengmeng Yang, et al.

    Major depressive disorder (MDD) remains a debilitating global health issue with limited treatment efficacy. Liver qi stagnation (or called liver depression


  • Open Access

    Association between preoperative anemia and postoperative delirium in elderly patients undergoing total hip arthroplasty with combined spinal-epidural anesthesia: A retrospective cohort study

    by Xianting Ke, Yi Liu, Xingyin Chen, Qiuyue Jiang, Hongrui Zhu, Qing Li

    The effect of preoperative anemia on postoperative delirium (POD) risk in elderly patients undergoing total hip arthroplasty (THA) with spinal-epidural anesthesia remains unclear. This study aimed to evaluate the association of preoperative anemia and its severity on POD occurrence in this population. This retrospective cohort study included 609 patients aged ≥ 65 years who underwent their first elective total THA with CSE between January 1, 2020, and December 31, 2024. Patients were stratified by preoperative anemia status using WHO criteria as hemoglobin < 13 g/dL males and < 12 g/dL females. Anemia severity was further stratified into mild or moderate-to-severe categories using a hemoglobin cutoff of 11 g/dL. Inverse probability of treatment weighting (IPTW) was employed to adjust for potential confounders. The primary outcome was the incidence of postoperative delirium. The secondary outcomes included in-hospital deep vein thrombosis, pulmonary infection, surgical site infection, and length of hospital stay (LOS). The overall POD incidence was 4.5 % (24/538). Moderate-to -severe anemia was significantly associated with increased POD risk (odds ratio [OR] 3.29; 95 % confidence interval [CI], 1.21–8.96; P = 0.02). No statistically significant differences were observed for secondary outcomes between groups. Moderate-to-severe preoperative anemia was significantly associated with an increased risk of postoperative delirium in elderly patients undergoing THA with combined spinal-epidural anesthesia. Further prospective studies are warranted to evaluate the efficacy of specific interventions aimed at correcting preoperative anemia in this patient population.


  • Open Access

    Effect of Fospropofol Disodium on Perioperative Neurocognitive Function in Elderly Patients Undergoing Total Hip Arthroplasty

    by Hongrui Zhu, Zaibao Wang, Sheng Ding, Chunliu Li, Li Xie, Yan Meng, Jiawei Xiao, Wuyang Zhang, Min Xu, Chen Gao, et al.

    Objective: This study aimed to compare the effects of fospropofol disodium and propofol on perioperative neurocognitive function in elderly patients undergoing total hip arthroplasty (THA), evaluating the non-inferiority of fospropofol disodium in preventing or reducing perioperative neurocognitive disorders (PND) and exploring optimal clinical anesthesia strategies. Methods: A total of 180 elderly patients (aged 65~80 years) scheduled for THA between November 2022 and November 2024 were randomly assigned to the fospropofol disodium group (Group F, n=90) or the propofol group (Group P, n=90). Cognitive function was assessed preoperatively (1 day before surgery) and postoperatively (1, 3, 7 days, and 1 month) using the Modified Mini-Mental State Examination (MMSE), 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM), Digit Span Test (DST), Verbal Fluency Test (VFT), and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). The incidence of postoperative cognitive dysfunction (POCD) and delirium (POD), hemodynamic parameters, and adverse events were compared between the two groups. Results: No significant differences were observed between the two groups in the incidence of POCD (p> 0.05) or POD (p> 0.05) at any postoperative time point. At the time point of 10 minutes after bone cement implantation (T4), the heart rate of patients in the Group F was higher than that of Group P (p < 0.0001). At the time of discharge from the PACU, the heart rate of patients in the Group F was lower than that of the Group P (p = 0.037). Group F exhibited higher mean arterial pressure (MAP) at the beginning of the operation (p=0.022) and a longer extubation time and waking time (p < 0.001) but had significantly lower incidences of injection pain (p=0.018) and postoperative nausea and vomiting (p=0.037). Binary logistic regression identified age as an independent risk factor for PND [OR=1.149, p=0.006], while preoperative MMSE score was a protective factor [OR=0.693, p = 0.002]. Conclusion: Fospropofol disodium may be a viable alternative in settings where injection pain and PONV are primary concerns, provided that hemodynamic stability is actively managed in elderly THA patients, with non-inferior efficacy in preventing PND compared to propofol and fewer adverse effects. Age and preoperative cognitive function are critical predictors of PND, warranting careful consideration in perioperative management.


  • Open Access

    Targeting microglial NAAA-regulated PEA signaling counters inflammatory damage and symptom progression of post-stroke anxiety

    by Tianyue Yin, Shuaijie Sun, Li Peng, Mengmeng Yang, Mengyu Li, Xinlu Yang, Fengyun Yuan, Hongrui Zhu, Sheng Wang

    Post-stroke anxiety (PSA) manifests as anxiety symptoms after stroke, with unclear mechanisms and limited treatment strategies. Endocannabinoids, reported to mitigate fear, anxiety, and stress, undergo dynamic alterations after stroke linked to prognosis intricately. However, endocannabinoid metabolism in ischemic microenvironment and their associations with post-stroke anxiety-like behavior remain largely uncovered. Our findings indicated that endocannabinoid metabolism was dysregulated after stroke, characterized by elevated N-palmitoylethanolamide (PEA) hydrolase N-acylethanolamine-acid amidase (NAAA) in activated microglia from ischemic area, accompanied by rapid PEA exhaustion. Microglial PEA metabolite exhaustion is directly associated with more severe pathological damage, anxiety symptoms and pain sensitivity. Naaa knockout or pharmacological supplementation to boost PEA pool content can effectively promote stroke recovery and alleviate anxiety-like behaviors. In addition, maintaining PEA pool content in ischemic area reduces overactivated microglia by confronting against mitochondria dysfunction and inflammasome cascade triggered IL-18 release and diffusion to contralateral hemisphere. Meanwhile, maintenance of microglial PEA pool content in ischemic-damaged lesion can preserve contralateral vCA1 synaptic integrity, enhancing anxiolytic pBLA-vCA1Calb1+ circuit activity by alleviating microglial phagocytosis-mediated synaptic loss. Thus, we conclude that microglial NAAA-regulated lipid signaling in the ischemic focus remodels contralateral anxiolytic circuit to participate in post-stroke anxiety progression. Blocking PEA signaling breakdown promotes stroke recovery and mitigates anxiety-like symptoms. Microglial NAAA-regulated lipid signaling involves with post-stroke anxiety. 1. PEA metabolite is exhausted in microglia after ischemic stroke. 2. NAAA signaling activation exacerbates ischemic brain injury and abnormal behavior. 3. PEA metabolism represses IL-18 inflammatory cascade mediated contralateral vCA1 circuit remodeling. 4. Boosting PEA metabolite mitigates anxiety-like behavior and improves function recovery after stroke.


  • Open Access

    Effects of Fospropofol Disodium and Propofol on the Postoperative Recovery of Elderly Patients Who Underwent Total Hip Arthroplasty: A Retrospective Study

    by Sheng Ding, Zaibao Wang, Chunliu Li, Guizhi Wang, Juan Li, Hongrui Zhu, Keqiang He

    Purpose: Propofol is widely used for general anesthesia in elderly patients. Fospropofol disodium, a precursor of propofol, may reduce the incidence of postoperative nausea and vomiting (PONV). However, the effects of these two drugs on patients’ postoperative recovery quality are unclear. The present study aimed to evaluate the effects of the two drugs on postoperative recovery quality in elderly patients who underwent total hip arthroplasty. Patients and Methods: We retrospectively analyzed 168 patients from the First Affiliated Hospital of USTC from October 2022 to June 2024. These individuals were assigned to fospropofol disodium group (F) or propofol group (P) according to the patients’ anesthesia induction and maintenance medication. The primary outcome was the rate of occurrence of PONV. The secondary outcomes included the time of extubation and the time of stay in post-anesthesia care unit (PACU), hospital length of stay, perioperative hemodynamic data and patients’ liver and renal functions. Results: PONV occurred to be lesser in group F than in group P (15.94% vs 33.33%, P < 0.05). Group P spent less in the extubation time (25.71 vs 33.36 min, P < 0.05) and PACU stay length (62.61 vs 65.65 min, P > 0.05), but hospital length of stay is longer (6.24 vs 5.8 days, P > 0.05). Liver and renal functions indexes and hemodynamic data between the 2 groups were similar (P > 0.05). The type of drug was a factor affecting the time of extubation. The type of drug and the patient’s gender were influential factors in the incidence of PONV. Conclusion: Fospropofol disodium reduces the incidence of PONV in patients. And the effects of fospropofol disodium on postoperative recovery quality are similar to that of propofol in older patients who underwent total hip arthroplasty.